Primary information |
---|
CancerPDF_ID | CancerPDF_ID3265 |
PMID | 21267442 |
Peptide Sequence | NA |
Peptide Sequence in Publication | NA |
Protein Name | Apolipoprotein C-I |
UniprotKB Entry Name | APOC1_HUMAN |
Biofluid | Serum |
M/Z | 6431 |
Charge | NA |
Mass/H+ | NA |
Mass (in Daltons) | NA |
Profiling Technique | MALDI-TOF |
Peptide Identification Technique | LC-MS-MS/MS |
Quantification Technique | LC-ESI-MS |
Labeling | Label Free |
FDR | NA |
p-Value | less than 0.05 |
Software | NA |
Length of Peptide | NA |
Cancer Type | Stomach adenocarcinoma |
Database for Peptide search | NA |
Modification | NA |
Number of Patients | 41 and 21 patients are in training dataset and testing dataset respectively; 21 and 12 Normal healthy individual s are in training dataset and testing dataset respectively |
Regulation/Differential Expression | Differentially expressed in cancer patients as cpmpare to normal |
Validation | Independent validation |
Sensitivity | 87/90 |
Specificity | 37/52 |
Accuracy | 88.4% and 74.4% for training and testing respectively |
Secondary information |
---|
Peptide Atlas | NA |
IEDB | |